Detalles de la búsqueda
1.
Patient and provider factors associated with colorectal cancer screening among average risk health plan enrollees in the US, 2015-2018.
BMC Health Serv Res
; 23(1): 550, 2023 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37237408
2.
The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors.
Oncologist
; 26(7): e1205-e1215, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955118
3.
Increasing prevalence of metastatic castration-resistant prostate cancer in a managed care population in the United States.
Cancer Causes Control
; 32(12): 1365-1374, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34386852
4.
The Identification and Cost of Acute Chronic Obstructive Pulmonary Disease Exacerbations in a United States Population Healthcare Claims Database.
COPD
; 17(5): 499-508, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32962447
5.
Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer.
Oncologist
; 24(9): 1209-1218, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796156
6.
Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
Oncologist
; 24(9): 1219-1228, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30808814
7.
Burden of illness in patients with treatment refractory myasthenia gravis.
Muscle Nerve
; 2018 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29486521
8.
Management of a Rare Disease Population: A Model for Identifying a Patient Population With Tuberous Sclerosis Complex.
Manag Care
; 26(8): 34-41, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28895825
9.
An Evaluation of Algorithms for Identifying Metastatic Breast, Lung, or Colorectal Cancer in Administrative Claims Data.
Med Care
; 53(7): e49-57, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23524464
10.
Diagnostic testing managed by hematopathology specialty and other laboratories: costs and patient diagnostic outcomes.
BMC Clin Pathol
; 14: 17, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24817828
11.
Colorectal screening among average risk individuals in the United States, 2015-2018.
Prev Med Rep
; 31: 102082, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36479238
12.
Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Expert Rev Pharmacoecon Outcomes Res
; 23(7): 843-852, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37462667
13.
Palbociclib Adherence and Persistence in Patients with Hormone Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer.
Patient Prefer Adherence
; 17: 1049-1062, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37096162
14.
Gaps in hepatocellular carcinoma surveillance in a United States cohort of insured patients with cirrhosis.
Curr Med Res Opin
; 38(12): 2163-2173, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111416
15.
Gaps in hepatocellular carcinoma surveillance among insured patients with hepatitis B infection without cirrhosis in the United States.
Hepatol Commun
; 6(12): 3443-3456, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36178256
16.
Opioid Use Associated With Higher Costs Among Patients With Inflammatory Bowel Disease.
Crohns Colitis 360
; 3(2): otab021, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36778940
17.
Mental Health Costs of Inflammatory Bowel Diseases.
Inflamm Bowel Dis
; 27(1): 40-48, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32095835
18.
Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.
J Manag Care Spec Pharm
; 26(6): 729-740, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32463768
19.
The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
Inflamm Bowel Dis
; 26(1): 1-10, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112238
20.
Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.
Rheumatol Ther
; 2(2): 127-139, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27747532